Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats.
about
Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation.Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein.Gene-environment interactions: key to unraveling the mystery of Parkinson's diseasePesticides, microglial NOX2, and Parkinson's diseaseMitochondrial DNA and primary mitochondrial dysfunction in Parkinson's disease.Considerations on the role of environmental toxins in idiopathic Parkinson's disease pathophysiologyToxin-induced models of Parkinson's disease.Transcriptome analysis of a rotenone model of parkinsonism reveals complex I-tied and -untied toxicity mechanisms common to neurodegenerative diseases.Pathogenesis of Parkinson disease--the gut-brain axis and environmental factors.Mutational analysis of DJ-1 in Drosophila implicates functional inactivation by oxidative damage and aging.Rotenone decreases intracellular aldehyde dehydrogenase activity: implications for the pathogenesis of Parkinson's disease.Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease.A guide to neurotoxic animal models of Parkinson's diseaseAnti-oxidant polydatin (piceid) protects against substantia nigral motor degeneration in multiple rodent models of Parkinson's diseaseClassic and new animal models of Parkinson's disease.Mitochondrial dysfunction and oxidative stress promote apoptotic cell death in the striatum via cytochrome c/caspase-3 signaling cascade following chronic rotenone intoxication in ratsNeurodegenerative disorders: Parkinson's disease and Huntington's diseaseAlterations of striatal glutamate transmission in rotenone-treated mice: MRI/MRS in vivo studies.Direct intranigral injection of dopaminochrome causes degeneration of dopamine neuronsModulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease.Adenosine A2A Receptor Blockade Prevents Rotenone-Induced Motor Impairment in a Rat Model of Parkinsonism.The dopaminergic nigrostriatal system and Parkinson's disease: molecular events in development, disease, and cell death, and new therapeutic strategies.Molecular pathogenesis, experimental models and new therapeutic strategies for Parkinson's disease.Animal models of Parkinson's disease progressionNeurodegenerative diseases: neurotoxins as sufficient etiologic agents?Low dose rotenone treatment causes selective transcriptional activation of cell death related pathways in dopaminergic neurons in vivo.Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson's disease.Mitochondrial toxins in Basal Ganglia disorders: from animal models to therapeutic strategies.Targeting the progression of Parkinson's disease.Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery.Rational therapeutic approaches to progressive supranuclear palsy.Vulnerability of mesostriatal dopaminergic neurons in Parkinson's diseaseThe pedunculopontine nucleus area: critical evaluation of interspecies differences relevant for its use as a target for deep brain stimulation.Tracking extranigral degeneration in animal models of Parkinson's disease: quest for effective therapeutic strategies.Mitochondrial dysfunction as a therapeutic target in progressive supranuclear palsy.Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson's disease models.Agrochemicals, α-synuclein, and Parkinson's disease.The centrality of mitochondria in the pathogenesis and treatment of Parkinson's disease.Molecular, Neurochemical, and Behavioral Hallmarks of Reserpine as a Model for Parkinson's Disease: New Perspectives to a Long-Standing Model.Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.
P2860
Q24815148-3A0EE783-8F18-4B7D-AB01-BEA3E4A88735Q26269955-126E888C-C571-4BA4-9088-C5DE0C5745BDQ28388674-72AC370C-7A33-47D3-BE1A-49601FFD69F5Q28397585-9C0AB223-E5B9-4E00-A45A-3ACC510C93B0Q33364885-F1F3531E-AEB1-4C4A-9B8D-4DABB80E4769Q33603777-1993AF2A-2C1B-43B9-B10D-7B73159F38CAQ33844749-277E26D5-4B9E-46C1-97A2-C57BF9E9CC11Q34412714-E3121885-913E-4351-8A3F-2D707FE65DF4Q34674177-23743137-8D65-4124-AB90-824CE68C4264Q34944292-00B2390F-E76C-4A5F-AE15-3C59A1A006A8Q35181537-41431F21-9E3A-4383-9C2E-BC052ED163F6Q35589979-8993E6AD-DE7D-4086-AD05-4C92DC89CB11Q35603488-604B638C-8737-4CA3-B6D5-1F043AE2489BQ35863280-801959E7-B3DD-46EA-BC28-76A01CC23223Q35875871-28DB8D97-93B2-4D95-8888-46AD8CC96993Q36197290-88558862-E0D2-49B2-B13A-AC2C52AE943AQ36198011-089CFB18-0036-43BD-953A-F143094417DFQ36302933-9F50B50B-A8FE-4797-93BD-E11E1217F3E9Q36505602-5D1DC7CA-544E-4B72-8843-E41A7D493506Q36616362-0D352E37-133D-4C87-8080-669B81B9B21CQ36627429-C85A6F14-7F01-4386-8243-7EB48164F003Q36709957-8E116629-6FE8-4F02-BE73-CC77B6A3D5B3Q36883776-510E20D4-F5AF-4B5B-B502-47338B6EEA37Q36924624-9046F9CE-9038-4CEA-9249-AB6358919004Q36994301-9F58F6DC-DE8D-4B21-9283-7B3ED311262AQ37063461-35D007F0-B05D-4AA0-AC00-AAECF3AAFEE5Q37110410-E7B1384F-D40B-4B14-B8E9-A6E554C3BF3FQ37211755-B4707AD6-59D2-4516-A2D7-F892A8F6CA26Q37299619-E69C0A9F-C2F3-4D92-B62E-BB600F785673Q37721641-A62FA5E7-FFC4-46B8-978B-1636B694A87DQ37753509-CE356C07-E92D-46EB-A6E4-2E254619AD4EQ37809751-FECCF10E-A4EA-47B3-893D-43462D6F6A89Q37819451-1112CCC0-85C1-42B2-A4D0-8C902A667206Q37880260-87B68888-7F11-4763-BEC1-0B2F928EEA77Q37906364-3B24F789-7D06-42EA-A066-99BFA2582D60Q38009051-E1FD4259-2CED-41D4-8E70-44CA7EA4C562Q38039020-4366330C-9B57-4BC2-BAA7-445D6D2535B2Q38202314-7B713F05-D121-4953-888C-2326F1B8BAF4Q38366271-1E6FE3FD-2019-455C-8ED8-C1C4786383E3Q38598375-630BF4F4-C9A7-4D5D-8414-BCABA9C24F91
P2860
Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Chronic systemic complex I inh ...... tisystem degeneration in rats.
@en
Chronic systemic complex I inh ...... tisystem degeneration in rats.
@nl
type
label
Chronic systemic complex I inh ...... tisystem degeneration in rats.
@en
Chronic systemic complex I inh ...... tisystem degeneration in rats.
@nl
prefLabel
Chronic systemic complex I inh ...... tisystem degeneration in rats.
@en
Chronic systemic complex I inh ...... tisystem degeneration in rats.
@nl
P2093
P2860
P1476
Chronic systemic complex I inh ...... tisystem degeneration in rats.
@en
P2093
Annick Prigent
Etienne C Hirsch
Günter U Höglinger
Jean Féger
Karine Parain
Merle Ruberg
Pierre Champy
P2860
P304
P356
10.1046/J.1471-4159.2003.01533.X
P407
P577
2003-02-01T00:00:00Z